Celebrate 10 Years of European Microbiome Innovation
Standing as the field’s definitive event uniting stakeholders across biotech, academia, investment and more, the 10th Microbiome Movement Summit Europe remains the only forum driving the translation of microbial research into impactful therapeutics for patients across a variety of indications.
As clinical readouts continue to roll in, next year’s meeting looks to dive deeper than the standard readouts, to understand the mechanistic process of these therapeutics, potential implications in broader indications or combination therapies, and how these scientific fundamentals can ultimately support translatability to clinical efficacy and patient benefit.
What Can You Expect in 2026?
Explore Clinical Trial Design Innovations Across Modalities
You will gain actionable insights into optimising clinical trial design for LBPs, FMTs, and novel consortia, from patient selection and endpoint refinement to combination strategies. Unpack case studies from Concerto Biosciences, AOBiome Therapeutics, and Microviable Therapeutics to highlight how mechanistic understanding can reshape trial success.
Unlock Emerging Therapeutic Frontiers in GI & Beyond
Discover how the microbiome is transforming treatments across dermatology, metabolic disorders, respiratory disease, and the gut–brain axis. From dual-strain LBPs for atopic dermatitis, to microbial co-therapies to treat neuroinflammation, expect to delve into cross-indication innovation.
Navigate the Evolving Investment & Commercial Landscape
Hear directly from leading investors including Seventure Partners, CSB, and Zcube, Zambon Research Venture on how to build microbiome ventures that attract capital. Gain insights into structuring deals, demonstrating scalability, and positioning platforms for strategic investment. Early-stage companies will also have the opportunity to pitch live, receiving feedback from investors and industry experts to foster visibility and potential partnerships.
Delve into Mechanisms of Action with Cutting-Edge Analytical Tools
Explore how AI, spatial biology, and multiomic integration are advancing target discovery, strain selection, and clinical translation. KU Leuven and PharmaBiome will demonstrate how to overcome data integrity challenges and scale innovation from bench to bedside.
Explore the Complete Event Programme
- 20+ World-Class Speakers
- Unrivalled Networking with a Tailored Group of Peers
- Clinical Updates from Industry Leaders
- Europe’s Longest Standing and Definitive Microbiome Forum
Attending Companies Include
Dive into the Agenda
Hear the latest breakthroughs and gain exclusive insights in our content-led presentation, interactive roundtables, and investor pitching session.
Showcase Your Solutions
Position your organisation alongside other industry-leading service providers to ensure your brand is front of mind for microbiome drug developers.
Join The Microbiome Community
Be part of in-depth conversations with industry and academic peers to uncover critical insights unavailable through other channels.